Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T30876 |
CHF 2819
Ganstigmine HCl,CHF-2819,Ganstigmine hydrochloride,CHF2819 |
||
CHF 2819 is a novel orally active acetylcholinesterase inhibitor (AChE) developed for the treatment of Alzheimer's disease (AD). CHF 2819 is a selective inhibitor of AChE, it is 115 times more potent against this enzyme than against butyrylcholinesterase (BuChE). |